Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

被引:6317
作者
Rizvi, Naiyer A. [1 ,2 ]
Hellmann, Matthew D. [1 ,2 ]
Snyder, Alexandra [1 ,2 ,3 ]
Kvistborg, Pia [4 ]
Makarov, Vladimir [3 ]
Havel, Jonathan J. [3 ]
Lee, William [5 ]
Yuan, Jianda [6 ]
Wong, Phillip [6 ]
Ho, Teresa S. [6 ]
Miller, Martin L. [7 ]
Rekhtman, Natasha [8 ]
Moreira, Andre L. [8 ]
Ibrahim, Fawzia [1 ]
Bruggeman, Cameron [9 ]
Gasmi, Billel [10 ]
Zappasodi, Roberta [10 ]
Maeda, Yuka [10 ]
Sander, Chris [7 ]
Garon, Edward B. [11 ]
Merghoub, Taha [1 ,10 ]
Wolchok, Jedd D. [1 ,2 ,10 ]
Schumacher, Ton N. [4 ]
Chan, Timothy A. [2 ,3 ,5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
[2] Weill Cornell Med Coll, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA
[4] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands
[5] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA
[6] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, Immune Monitoring Core, New York, NY 10065 USA
[7] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA
[8] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[9] Columbia Univ, Dept Math, New York, NY 10027 USA
[10] Mem Sloan Kettering Canc Ctr, Ludwig Collaborat Lab, New York, NY 10065 USA
[11] Univ Calif Los Angeles, David Geffen Sch Med, Santa Monica, CA 90404 USA
关键词
EXOME ANALYSIS REVEALS; TUMOR; IPILIMUMAB; NIVOLUMAB; MPDL3280A; RESPONSES; ANTIGENS; ANTIBODY; EPITOPE;
D O I
10.1126/science.aaa1348
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are revolutionizing cancer treatment. To unravel the genomic determinants of response to this therapy, we used whole-exome sequencing of non-small cell lung cancers treated with pembrolizumab, an antibody targeting programmed cell death-1 (PD-1). In two independent cohorts, higher nonsynonymous mutation burden in tumors was associated with improved objective response, durable clinical benefit, and progression-free survival. Efficacy also correlated with the molecular smoking signature, higher neoantigen burden, and DNA repair pathway mutations; each factor was also associated with mutation burden. In one responder, neoantigen-specific CD8+ T cell responses paralleled tumor regression, suggesting that anti-PD-1 therapy enhances neoantigen-specific T cell reactivity. Our results suggest that the genomic landscape of lung cancers shapes response to anti-PD-1 therapy.
引用
收藏
页码:124 / 128
页数:5
相关论文
共 45 条
[1]   The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology [J].
Abaan, Ogan D. ;
Polley, Eric C. ;
Davis, Sean R. ;
Zhu, Yuelin J. ;
Bilke, Sven ;
Walker, Robert L. ;
Pineda, Marbin ;
Gindin, Yevgeniy ;
Jiang, Yuan ;
Reinhold, William C. ;
Holbeck, Susan L. ;
Simon, Richard M. ;
Doroshow, James H. ;
Pommier, Yves ;
Meltzer, Paul S. .
CANCER RESEARCH, 2013, 73 (14) :4372-4382
[2]   Signatures of mutational processes in human cancer [J].
Alexandrov, Ludmil B. ;
Nik-Zainal, Serena ;
Wedge, David C. ;
Aparicio, Samuel A. J. R. ;
Behjati, Sam ;
Biankin, Andrew V. ;
Bignell, Graham R. ;
Bolli, Niccolo ;
Borg, Ake ;
Borresen-Dale, Anne-Lise ;
Boyault, Sandrine ;
Burkhardt, Birgit ;
Butler, Adam P. ;
Caldas, Carlos ;
Davies, Helen R. ;
Desmedt, Christine ;
Eils, Roland ;
Eyfjord, Jorunn Erla ;
Foekens, John A. ;
Greaves, Mel ;
Hosoda, Fumie ;
Hutter, Barbara ;
Ilicic, Tomislav ;
Imbeaud, Sandrine ;
Imielinsk, Marcin ;
Jaeger, Natalie ;
Jones, David T. W. ;
Jones, David ;
Knappskog, Stian ;
Kool, Marcel ;
Lakhani, Sunil R. ;
Lopez-Otin, Carlos ;
Martin, Sancha ;
Munshi, Nikhil C. ;
Nakamura, Hiromi ;
Northcott, Paul A. ;
Pajic, Marina ;
Papaemmanuil, Elli ;
Paradiso, Angelo ;
Pearson, John V. ;
Puente, Xose S. ;
Raine, Keiran ;
Ramakrishna, Manasa ;
Richardson, Andrea L. ;
Richter, Julia ;
Rosenstiel, Philip ;
Schlesner, Matthias ;
Schumacher, Ton N. ;
Span, Paul N. ;
Teague, Jon W. .
NATURE, 2013, 500 (7463) :415-+
[3]   Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers [J].
Andersen, Rikke Sick ;
Kvistborg, Pia ;
Frosig, Thomas Morch ;
Pedersen, Natasja W. ;
Lyngaa, Rikke ;
Bakker, Arnold H. ;
Shu, Chengyi Jenny ;
Straten, Per Thor ;
Schumacher, Ton N. ;
Hadrup, Sine Reker .
NATURE PROTOCOLS, 2012, 7 (05) :891-902
[4]   PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].
Ansell, Stephen M. ;
Lesokhin, Alexander M. ;
Borrello, Ivan ;
Halwani, Ahmad ;
Scott, Emma C. ;
Gutierrez, Martin ;
Schuster, Stephen J. ;
Millenson, Michael M. ;
Cattry, Deepika ;
Freeman, Gordon J. ;
Rodig, Scott J. ;
Chapuy, Bjoern ;
Ligon, Azra H. ;
Zhu, Lili ;
Grosso, Joseph F. ;
Kim, Su Young ;
Timmerman, John M. ;
Shipp, Margaret A. ;
Armand, Philippe .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319
[5]   Exploiting the Mutanome for Tumor Vaccination [J].
Castle, John C. ;
Kreiter, Sebastian ;
Diekmann, Jan ;
Loewer, Martin ;
Van de Roemer, Niels ;
de Graaf, Jos ;
Selmi, Abderraouf ;
Diken, Mustafa ;
Boegel, Sebastian ;
Paret, Claudia ;
Koslowski, Michael ;
Kuhn, Andreas N. ;
Britten, Cedrik M. ;
Huber, Christoph ;
Tuereci, Oezlem ;
Sahin, Ugur .
CANCER RESEARCH, 2012, 72 (05) :1081-1091
[6]  
COLEY WB, 1991, CLIN ORTHOP RELAT R, P3
[7]   Comprehensive molecular profiling of lung adenocarcinoma [J].
Collisson, Eric A. ;
Campbell, Joshua D. ;
Brooks, Angela N. ;
Berger, Alice H. ;
Lee, William ;
Chmielecki, Juliann ;
Beer, David G. ;
Cope, Leslie ;
Creighton, Chad J. ;
Danilova, Ludmila ;
Ding, Li ;
Getz, Gad ;
Hammerman, Peter S. ;
Hayes, D. Neil ;
Hernandez, Bryan ;
Herman, James G. ;
Heymach, John V. ;
Jurisica, Igor ;
Kucherlapati, Raju ;
Kwiatkowski, David ;
Ladanyi, Marc ;
Robertson, Gordon ;
Schultz, Nikolaus ;
Shen, Ronglai ;
Sinha, Rileen ;
Sougnez, Carrie ;
Tsao, Ming-Sound ;
Travis, William D. ;
Weinstein, John N. ;
Wigle, Dennis A. ;
Wilkerson, Matthew D. ;
Chu, Andy ;
Cherniack, Andrew D. ;
Hadjipanayis, Angela ;
Rosenberg, Mara ;
Weisenberger, Daniel J. ;
Laird, Peter W. ;
Radenbaugh, Amie ;
Ma, Singer ;
Stuart, Joshua M. ;
Byers, Lauren Averett ;
Baylin, Stephen B. ;
Govindan, Ramaswamy ;
Meyerson, Matthew ;
Rosenberg, Mara ;
Gabriel, Stacey B. ;
Cibulskis, Kristian ;
Sougnez, Carrie ;
Kim, Jaegil ;
Stewart, Chip .
NATURE, 2014, 511 (7511) :543-550
[8]   Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers [J].
Dogan, Snjezana ;
Shen, Ronglai ;
Ang, Daphne C. ;
Johnson, Melissa L. ;
D'Angelo, Sandra P. ;
Paik, Paul K. ;
Brzostowski, Edyta B. ;
Riely, Gregory J. ;
Kris, Mark G. ;
Zakowski, Maureen F. ;
Ladanyi, Marc .
CLINICAL CANCER RESEARCH, 2012, 18 (22) :6169-6177
[9]   Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity [J].
Duan, Fei ;
Duitama, Jorge ;
Al Seesi, Sahar ;
Ayres, Cory M. ;
Corcelli, Steven A. ;
Pawashe, Arpita P. ;
Blanchard, Tatiana ;
McMahon, David ;
Sidney, John ;
Sette, Alessandro ;
Baker, Brian M. ;
Mandoiu, Ion I. ;
Srivastava, Pramod K. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (11) :2231-2248
[10]  
Garon EB, 2014, ANN ONCOL, V25